comparemela.com

Latest Breaking News On - Duke cancer institute - Page 4 : comparemela.com

ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring

Personalis, Inc. announced today that data presented at the American Society for Clinical Oncology (ASCO) oral podium talks in Chicago, IL demonstrated that the Personalis NeXT Personal test had exceptional detection rates and performance for.

California
United-states
Hebron
Israel-general
Israel
London
City-of
United-kingdom
Chicago
Illinois
Fremont
American

Caring House Receives $3 Million Challenge Grant for

Caring House Receives $3 Million Challenge Grant for
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Chapel-hill
North-carolina
United-states
Winston-salem
Sasha-zarzour
Chris-ayers
Jama-campbell
Member-services
Duke-cancer-institute
National-credit-union-administration
Foundation-board
Room-to-heal-campaign-for-expansion

BostonGene Announces Seven Abstract Acceptances at the 2024 American Society of Clinical Oncology Annual Meeting

BostonGene Announces Seven Abstract Acceptances at the 2024 American Society of Clinical Oncology Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states
Texas
Chicago
Illinois
Mccormick-place
Massachusetts
American
Nikita-kotlov
Jason-mouabbi
Jiayi-huang
Mccormick-place-convention-center
Duke-cancer-institute

5 FDA Solid Tumor Approvals from Spring 2024

5 FDA Solid Tumor Approvals from Spring 2024
curetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from curetoday.com Daily Mail and Mail on Sunday newspapers.

Dana-farber-cancer-institute
Massachusetts
United-states
North-carolina
Boston
Daniel-landi
Sarah-sammons
Jay-bradner
Amgen
Duke-cancer-institute-in-durham
Drug-administration
National-cancer-institute

Tivumecirnon Plus Pembrolizumab Displays Activity and Tolerability in HNSCC

Jameel Muzaffar, MD, discusses findings from the phase 2 portion of the FLX475-02 study examining tivumecirnon plus pembrolizumab in HNSCC.

Duke-university
North-carolina
United-states
Jameel-muzaffar
Duke-cancer-institute
Duke-university-school

vimarsana © 2020. All Rights Reserved.